Literature DB >> 17961994

Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study.

José L Arias1, M A Adolfina Ruiz, Margarita López-Viota, Angel V Delgado.   

Abstract

Because of the fundamental importance of new therapeutic routes for cancer treatment, a number of systems based on colloidal particles as vehicles for the delivery of chemotherapeutic agents have been devised. The target is always to provide the proper dose of the antitumour agent only at the desired locus of action, thus reducing the unwanted side effects. The systems studied in this work are nanospheres of the biodegradable polymers poly(ethyl-2-cyanoacrylate), poly(butylcyanoacrylate), poly(hexylcyanoacrylate) and poly(octylcyanoacrylate), all suitable for parenteral administration, as vehicles for 5-fluorouracil, a well studied drug used for the treatment of solid tumours. Two loading methods have been analyzed: the first one is based on drug addition during the process of generation of the particles, by an anionic emulsion/polymerization procedure, and the subsequent drug trapping in the polymeric network. The second method is based on surface adsorption in already formed nanoparticles, after incubation in the drug solution. A detailed investigation of the capabilities of the polymer particles to load this drug is described. The main factors determining the drug incorporation to the polymer network were the type of monomer, the pH and the drug concentration. The release kinetics of 5-fluorouracil is found to be controlled by the pH of the release medium, the type of drug incorporation and the type of polymer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961994     DOI: 10.1016/j.colsurfb.2007.09.018

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  9 in total

1.  Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer.

Authors:  Raúl Ortiz; Laura Cabeza; José L Arias; Consolación Melguizo; Pablo J Álvarez; Celia Vélez; Beatriz Clares; Antonia Áranega; Jose Prados
Journal:  AAPS J       Date:  2015-04-17       Impact factor: 4.009

2.  Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.

Authors:  Abdelkader E Ashour; Mohammad Badran; Ashok Kumar; Tajamul Hussain; Ibrahim A Alsarra; Alaa Eldeen B Yassin
Journal:  Int J Nanomedicine       Date:  2019-11-28

3.  ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy.

Authors:  Srinivasan Ayyanaar; Chandrasekar Balachandran; Rangaswamy Chinnabba Bhaskar; Mookkandi Palsamy Kesavan; Shin Aoki; Ramachandran Palpandi Raja; Jegathalaprathaban Rajesh; Thomas J Webster; Gurusamy Rajagopal
Journal:  Int J Nanomedicine       Date:  2020-05-12

4.  5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.

Authors:  Raúl Ortiz; José Prados; Consolación Melguizo; José L Arias; M Adolfina Ruiz; Pablo J Alvarez; Octavio Caba; Raquel Luque; Ana Segura; Antonia Aránega
Journal:  Int J Nanomedicine       Date:  2012-01-09

5.  Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles.

Authors:  Laura Cabeza; Raúl Ortiz; José L Arias; Jose Prados; Maria Adolfina Ruiz Martínez; José M Entrena; Raquel Luque; Consolación Melguizo
Journal:  Int J Nanomedicine       Date:  2015-02-13

6.  Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer.

Authors:  Shashank Tummala; M N Satish Kumar; Ashwati Prakash
Journal:  Saudi Pharm J       Date:  2014-12-11       Impact factor: 4.330

7.  Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles.

Authors:  Consolación Melguizo; Laura Cabeza; Jose Prados; Raúl Ortiz; Octavio Caba; Ana R Rama; Ángel V Delgado; José L Arias
Journal:  Drug Des Devel Ther       Date:  2015-12-14       Impact factor: 4.162

8.  In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.

Authors:  Mohamed Nasr; Mohamed K Ghorab; Ahmed Abdelazem
Journal:  Acta Pharm Sin B       Date:  2014-12-29       Impact factor: 11.413

Review 9.  Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems.

Authors:  José L Arias
Journal:  Molecules       Date:  2008-10-01       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.